Patent Examiner Jason E. Flick
Art Unit 3783 · Surgery: Medical & Surgical Instruments & Devices · Tech Center 3700 · 195 applications since 2021
Jason E. Flick is a USPTO patent examiner in Art Unit 3783 (Surgery: Medical & Surgical Instruments & Devices) who has examined 195 applications in filing years 2021–2025. Examiner Flick's allowance rate is 88.0%, above the 82.1% USPTO average; the examiner ranks easier than 70% of examiners.
Data through March 2026 · Source: USPTO Patent Center (formerly PAIR) · Methodology
Overview
FreeExaminer details
- Art unit3783 · Surgery: Medical & Surgical Instruments & Devices
- Title / gradePrimary Patent Examiner · GS-14
- Service18 years
- Phone(571) 270-7024
- Email[email protected]
- LocationAlexandria, VA 22314
- On office actionsFlick, Jason E
Examiner Flick can allow an application without a supervisory sign-off, which is why an examiner interview can be decisive.
How to improve your odds with Examiner Flick
- Interview results are mixed year to year. The largest measured lift was 17.3 points in 2021, but at least one year ran the other way; weigh the year-by-year table below.
- Plan for the timeline. First office action averages 815 days vs the 589-day USPTO norm.
- Expect a §112. Disclosure is the most-issued rejection (70), and applicants overcame it 95.1% of the time.
- The data favored an RCE here. Cases with an RCE allowed at 100.0% versus 91.7% without in 2023.
- This docket has supported broader claims. With a 88.0% allowance rate, preserving breadth where the specification supports it has been viable.
Historical patterns from this examiner's past cases, shown for general information. This is not legal advice and does not predict the outcome of any specific application. Decisions about interviews, RCEs, and claim strategy should be made with a licensed patent attorney or agent.
Rejection patterns & how they get overcome
FreeREMARKS: Applicant respectfully traverses the rejection under 35 U.S.C. §112. The specification provides written-description and enablement support for the claimed subject matter, and the claim terms are definite when read in light of the specification by one of ordinary skill in the art, at least because ...
Just got an office action from Examiner Flick?
Draft a response grounded in Examiner Flick's complete prosecution history: the rejection patterns, the interview record, and the arguments that have actually worked. Powered by Boundly AI Studio.
Trends
| Year | Interview rate | Allowance w/ interview | Allowance w/o | Delta |
|---|---|---|---|---|
| 2024 | 13.3% | 100.0% | 100.0% | 0.0pp |
| 2023 | 6.3% | 100.0% | 93.3% | +6.7pp |
| 2022 | 3.5% | 50.0% | 88.6% | -38.6pp |
| 2021 | 5.4% | 100.0% | 82.7% | +17.3pp |
RCE behavior
Allowance after a Request for Continued Examination versus without one, per year. Use it to judge whether an RCE is worth the cost in front of Examiner Flick.
| Year | RCE rate | Allowance w/ RCE | Allowance w/o | Delta |
|---|---|---|---|---|
| 2023 | 9.5% | 100.0% | 91.7% | +8.3pp |
| 2022 | 15.8% | 100.0% | 82.8% | +17.2pp |
| 2021 | 23.2% | 100.0% | 78.0% | +22.0pp |
Recent outcomes
Free🔒 Case detail: members| App # | Title | Outcome | OAs | Arguments & redline |
|---|---|---|---|---|
| 17/734481 | Medical Device Disposables Information Systems and Methods | Patented | 1 | 🔒 View |
| 17/321127 | Infusion Pump Sensing System | Patented | 2 | 🔒 View |
| 17/937514 | Sanitizing Caps for Medical Connectors | Patented | 1 | 🔒 View |
| 18/114332 | Liquid Medicine Injection Device, Drug Injection Device, and Method for Determining Remaining Amount of Drug Thereof | Patented | 0 | 🔒 View |
Technology & expertise
Frequently asked questions
What is Examiner Jason E. Flick's allowance rate?
Is Examiner Flick a hard examiner?
Do examiner interviews help with Examiner Flick?
What is Examiner Flick's most common rejection?
Is an RCE worth filing with Examiner Flick?
How long until the first office action from Examiner Flick?
How do I contact Examiner Jason E. Flick?
Put Examiner Flick's data to work on your next response.
Full file-wrapper detail, winning arguments, and AI drafting in one workspace.